Tag: Brad Michel

Accenture announces acquisition of Bionest

Accenture has acquired Bionest, a strategy and consulting firm dedicated to addressing complex strategic decisions for leading biopharma organizations across innovative areas of science including precision medicine and diagnostics, oncology, cell & gene therapy (CGT), and rare diseases. Terms of the transaction were not disclosed.  Headquartered in New York with a European office in Paris, Bionest’s…